ライフサイエンスコーパス: needle biopsy

1 kidney transplant is currently diagnosed by needle biopsy.

2 3 benign papillary lesions diagnosed at core-needle biopsy.

3 ed on tissue obtained with image-guided core-needle biopsy.

4 c findings at the time of lumpectomy or core-needle biopsy.

5 nucleic acid yields from imaging-guided core needle biopsy.

6 the morbidity and mortality associated with needle biopsy.

7 Two small cancers were completely removed at needle biopsy.

8 tients, open biopsy was performed after core-needle biopsy.

9 of diagnostic techniques, particularly core needle biopsy.

10 as atypical ductal hyperplasia (ADH) by core needle biopsy.

11 on of (68)Ga-PSMA PET/CT in conjunction with needle biopsy.

12 out metastatic disease and diagnosed by core needle biopsy.

13 y were negatively correlated with receipt of needle biopsy.

14 redicated on the results of a patient's fine-needle biopsy.

15 mmogram and a target for stereotactic breast needle biopsy.

16 malignant changes in the vicinity of a core needle biopsy.

17 t as the one originally diagnosed with LN at needle biopsy.

18 cancer and a target for stereotactic breast needle biopsy.

19 kemia antigen CD34, coupled with a "magnetic needle" biopsy.

20 subpopulation of tissue specimens sampled by needle biopsies.

21 n-and are therefore suitable for analysis of needle biopsies.

22 stic sampling as an attractive surrogate for needle biopsies.

23 umbers of viable cells when compared to core needle biopsies.

24 m 23 patients undergoing stereotactic breast needle biopsies.

25 l open biopsy, 44 kidneys in 31 patients had needle biopsies.

26 itial surgical procedure: 9 open biopsies, 4 needle biopsies, 1 partial nephrectomy).

27 After US-guided core-needle biopsy, 115 (58%) of 198 patients were treated co

28 pared with those with ADH diagnosed via core needle biopsy (5%; 95% CI, 2.2%-8.9%).

29 tic yield (71.5% [40/56]) compared with core-needle biopsy (50% [17/34] P = .04) and fine needle aspi

30 almost three times as high as those for core-needle biopsy ($698 vs $243).

31 Among 572 scheduled stereotactic core-needle biopsies, 89 cases (16%) in 88 patients were canc

32 thermodilution blood flow measurements, and needle biopsies allowed the assessment of muscle oxygen

33 uided transsternal approach for coaxial core-needle biopsy allows safe access to masses in various lo

34 Numerous pathologic characteristics in needle biopsies and preoperative clinical findings were

35 Ultimately, we aim to guide percutaneous needle biopsies and provide a minimally invasive method

36 easibility profile similar to that of single-needle biopsy and (b) an absence of serious adverse even

37 high-risk (for cancer) breast tissue at core-needle biopsy and had undergone subsequent surgery or fo

38 problems and limitations of prognostic fine needle biopsy and molecular classifications.

39 uracy of other interventions, including core-needle biopsy and needle-localized open surgical biopsy.

40 mputed tomographic (CT)-guided transthoracic needle biopsy and otherwise would have required chest tu

41 planning and guiding subsequent percutaneous needle biopsy and patient care.

42 eral anesthesia in 14 patients who underwent needle biopsy and radio-frequency treatment.

43 operative MR imaging combined with MR-guided needle biopsy and/or MR-guided lesion localization or br

44 generate 2 x 10(6) cells in 5 to 6 days from needle biopsies, and can generate cultures from cryopres

45 miles from a radiologic facility performing needle biopsy, and no mammogram within 60 days before co

46 f, starting with its diagnosis, reporting on needle biopsy, and reviewing how the most frequently use

47 ic findings, the histologic findings at core-needle biopsy, and the findings at subsequent surgical e

48 of US-guided FNA is similar to that of core needle biopsy, and there were no complications in this s

49 Definitive surgical, core-needle biopsy, and/or follow-up information was availabl

50 r Child Health study proposes a percutaneous needle biopsy approach to obtain postmortem samples, rat

51 Patients underwent pretreatment core needle biopsy; archival tumor samples were also obtained

52 cancers (Gleason pattern 3, G3) detected on needle biopsies are generally viewed as indolent and sui

53 Needle biopsies are invasive and associated with patient

54 ular fine-needle aspiration and percutaneous needle biopsy are feasible alternatives in selected grou

55 with pure LN of a low-risk type diagnosed at needle biopsy are strongly encouraged to undergo a yearl

56 Eight of 18 lesions diagnosed with automated needle biopsy as ADH were determined at surgery to be br

57 Nine of 55 lesions diagnosed with automated needle biopsy as DCIS were diagnosed as infiltrating duc

58 d OCM, which has the potential to guide core needle biopsies, assess surgical margins, and evaluate n

59 in human vastus lateralis muscle obtained by needle biopsy basally and after insulin infusion in four

60 n cases referred for excisional biopsy after needle biopsy because of atypia or discordance, final su

61 Percutaneous core-needle biopsy can be an effective alternative to open bi

62 Transvitreal and transscleral needle biopsy can result in complications including vitr

63 pared with the Gleason score (GS) after core needle biopsy (CNB) in patients with low, medium and hig

64 Percutaneous core needle biopsy (CNB) is optimal for minimizing surgery fo

65 ELs) are a common histologic finding on core needle biopsy (CNB) of the breast.

66 Core needle biopsy (CNB) sampling is known to be inexpensive

67 biopsies (FNAB) controlled with CT and core-needle biopsy (CNB) under real-time CT fluoroscopy guida

68 olumnar cell lesions (CCLs) in a breast core needle biopsy (CNB).

69 surgeries was 33.7% for patients undergoing needle biopsy compared with 69.6% for those who did not

70 After needle biopsy, computed tomography (CT)-guided percutane

71 Low-strength evidence showed that core-needle biopsies conducted under stereotactic guidance wi

72 Furthermore, mock needle biopsy cores containing foci of prostate cancer e

73 Stereotactic core needle biopsy decreases the cost of diagnosis, but its i

74 Studies that compared core-needle biopsy diagnoses with open surgical diagnoses or

75 cheduled for an initial or repeated prostate needle biopsy due to suspicious digital rectal examinati

76 However, despite stereotactic guidance, core needle biopsy fails to retrieve microcalcifications in u

77 imaging-guided 9-gauge vacuum-assisted core-needle biopsy findings of 85 lesions in 75 patients aged

78 Transthoracic needle biopsy findings were positive for cancer in 40 ca

79 spectroscopy guidance of stereotactic breast needle biopsies for microcalcifications.

80 for spectroscopic validation of breast core needle biopsy for detection of microcalcifications that

81 01 patients who underwent transthoracic core needle biopsy for the KEYNOTE-001 (MK-3475) clinical tri

82 xpression profiling was performed on 50 core needle biopsies from 18 breast cancer patients using Aff

83 islets in pancreatectomies and percutaneous needle biopsies from 55 whole pancreas allografts.

84 chilles tendon by means of ultrasound-guided needle biopsies from the healing area of the Achilles te

85 els, human skeletal muscle cells obtained by needle biopsy from normal control subjects were grown in

86 Multisite stereotactic core needle biopsy had a positive effect on patient care in 2

87 The diagnosis of prostate cancer on needle biopsy has been refined because of the recent dis

88 grade prostatic intraepithelial neoplasia on needle biopsy has decreased to the point at which this a

89 s) are deadly paediatric brain tumours where needle biopsies help guide diagnosis and targeted therap

90 d ultrasound, physical examination, and fine needle biopsy if required to evaluate thyroid nodularity

91 and-guided CNB, image-guided vacuum assisted needle biopsy, image-guided fine needle aspiration, punc

92 e using 25-gauge vitrectomy as an adjunct to needle biopsy immediately before brachytherapy to minimi

93 Core-needle biopsy in comparison to fine-needle aspiration bi

94 specificity, and accuracy of US-guided core needle biopsy in differentiating benign from malignant l

95 nsitivity, specificity, and accuracy of core-needle biopsy in the detection of malignant neoplasms we

96 012, the proportion of ADH diagnosed by core needle biopsy increased from 21% to 77%.

97 Core needle biopsy increases patient satisfaction and reduces

98 Use of needle biopsy is a proposed quality measure in the diagn

99 CT-guided percutaneous needle biopsy is a safe, alternative method for obtainin

100 Conclusion Image-guided transthoracic core needle biopsy is an effective method for obtaining tissu

101 Image-guided 25-gauge needle biopsy is both feasible and safe.

102 Multisite stereotactic core needle biopsy is feasible, safe, and may influence treat

103 esions is necessary before stereotactic core-needle biopsy is scheduled.

104 Stereotactic core needle biopsy is the diagnostic procedure of choice for

105 Needle biopsy is underused in the United States, resulti

106 d approach to tumor sampling, often invasive needle biopsy, is unable to fully capture the spatial st

107 Large-core needle biopsy (LCNB) has become an alternative to surgic

108 tereotactic, 14-gauge, automated, large-core needle biopsy (LCNB) was performed in 483 consecutive no

109 At core-needle biopsy, lesions were diagnosed as papilloma (n =

110 At MR imaging-guided core-needle biopsy, malignancy was identified in 52 (61%) les

111 monitoring AMACR activity levels in prostate needle biopsies may have clinical applications.

112 tallic clips placed during stereotactic core-needle biopsy may differ substantially from the location

113 atic disease with the use of prognostic fine needle biopsy, Monosomy 3 a risk factor for metastatic d

114 Disease progression was verified at needle biopsy (n = 16), follow-up imaging (n = 14), and/

115 ne-needle aspiration (n = 55), 14-gauge core-needle biopsy (n = 81), or both (n = 14).

116 y (standard care; n=25) or CT-guided cutting needle biopsy (n=25).

117 DNA was extracted from fine needle biopsies of 73 primary breast cancers and 19 meta

118 emistry on formalin fixed, paraffin embedded needle biopsies of kidney and pancreas allografts.

119 Findings at 209 consecutive core-needle biopsies of lesions of the thyroid gland in 198 p

120 ODS: From January, 2012 to May 2013, 76 core-needle biopsies of lung and mediastinum tumors were cond

121 ations were compared with measurements on 10 needle biopsies of normal liver and four tumor biopsies.

122 Needle biopsies of skeletal muscle (vastus lateralis) we

123 Needle biopsies of the liver were performed on a cross-s

124 Four hundred twenty-three needle biopsies of the lung were performed in 390 patien

125 Transrectal ultrasound guided needle biopsies of the prostate are routinely performed

126 Needle biopsies of vastus lateralis muscle were obtained

127 Needle biopsies of vastus lateralis muscle were taken fr

128 r can be normalized after prolonged culture, needle biopsies of vastus lateralis were obtained from 8

129 Tissue collected by core needle biopsy of a left internal jugular lymph node demo

130 in recurrent disease is usually made by core needle biopsy of a single lesion, which may not represen

131 Nodal ultrasonography with needle biopsy of abnormal lymph nodes helps to define th

132 vances enabling computer-guided stereoscopic needle biopsy of calcified foci, histopathologic diagnos

133 US technique was used to identify and guide needle biopsy of enlarged supraclavicular lymph nodes (>

134 able with published results of transthoracic needle biopsy of larger lesions.

135 Transthoracic needle biopsy of mediastinal lymphadenopathy is a safe,

136 ty-five patients underwent stereotactic core needle biopsy of more than one site.

137 y 1995, 302 patients underwent transthoracic needle biopsy of pulmonary lesions.

138 Transthoracic needle biopsy of small pulmonary nodules can produce dia

139 Needle biopsy of such lesions, however, is best performe

140 es that nuclear medicine guided stereotactic needle biopsy of the breast in patients with positive sc

141 Ultrasound-guided core needle biopsy of the breast mass diagnoses an invasive d

142 dle track created by stereotactic large-core-needle biopsy of the breast.

143 elected cases by those performing large-core-needle biopsy of the breast.

144 Transthoracic needle biopsy of the hilum or mediastinum was performed

145 Thirty-eight patients underwent percutaneous needle biopsy of the liver with chemical measurement of

146 is could be histologically diagnosed without needle biopsy of the liver.

147 the injection site were confirmed by sextant needle biopsy of the prostate at 2 weeks.

148 ansrectal ultrasound guided systemic sextant needle biopsy of the prostate has been the procedure of

149 Sextant needle biopsy of the prostate was obtained at 2 (cohort

150 Core-needle biopsy of the renal cortex obtained during surgic

151 US-guided core-needle biopsy of the thyroid gland is a safe outpatient

152 ankle dorsiflexion (ADF) and then obtained a needle biopsy of tibialis anterior (TA) to analyze splic

153 and knowledge regarding downstream impact of needle biopsy on breast cancer care is incomplete.

154 Diagnosis of ADH on core needle biopsy or excisional biopsy in women undergoing m

155 sk for breast cancer and should undergo core-needle biopsy or needle localization with surgical biops

156 2 on gene-expression profiling, detected by needle biopsy or solid tumor biopsy.

157 5% CI, 1.04 to 4.13) and completion of first needle biopsy (OR, 3.02; 95% CI, 1.76 to 5.18) were asso

158 ed biopsies and 8.6 months for the automated needle biopsies (P < .0001).

159 Among 16 945 needle biopsies performed between April 1998 and August

160 in diagnostic techniques, specifically core needle biopsies performed under mammographic and ultraso

161 adiographs of the specimens obtained at core needle biopsy performed through the region of color leve

162 in the relative utilization of percutaneous needle biopsy (PNB) and imaging-guided percutaneous biop

163 tereotactic- and ultrasonography-guided core-needle biopsy procedures seem to be almost as accurate a

164 sion, in real-time, during stereotactic core needle biopsy procedures.

165 ted in patients who present with palpable or needle biopsy-proven axillary metastases, patients with

166 Surgeon-level interventions may improve needle biopsy rates and, accordingly, quality of care.

167 a false-positive screening without and with needle biopsy, respectively.

168 In 105 (74%) patients, core-needle biopsy results were concordant with results from

169 In 36 (26%) patients, inaccurate core-needle biopsy results were obtained: In nine, results we

170 Ultrasound-guided core needle biopsy revealed an infiltrating ductal carcinoma

171 Needle biopsies samples were taken from the vastus later

172 on was detectable for all genes in malignant needle biopsy samples (AUC: 0.80 to 0.98), confirming pr

173 ein synthesis in human skeletal muscle using needle biopsy samples and applied this technique to eluc

174 Overall mean number of core needle biopsy samples obtained was 7.9 samples.

175 r regular quantification of steroids in core needle biopsy samples of breast tissue to inform dosage

176 gs were compared with histopathology of core needle biopsy samples or with ultrasound follow-up data

177 ole sections, paired surgical resection/core needle biopsy samples, and paired samples from 69 patien

178 agnostics on patient blood, bone marrow, and needle biopsy samples.

179 may facilitate the analysis of miRNA in fine-needle-biopsy samples and even in single cells without e

180 echniques include stereotactic 14-gauge core-needle biopsy (SC bx), stereotactic 11-gauge suction-ass

181 ed the differences between stereotactic core needle biopsy (SCNBx) and needle localization surgical b

182 apillary lesions diagnosed as benign at core-needle biopsy should be surgically excised because a sub

183 Large-core needle biopsy showed diffuse calcifications within expan

184 gnostic purposes involving preoperative fine-needle biopsy specimens as well as to define targetable

185 n of AMACR protein expression in 94 prostate needle biopsy specimens demonstrated 97% sensitivity and

186 A total of 151 pancreas transplant needle biopsy specimens from 57 patients were evaluated.

187 xpression profile analysis of formalin-fixed needle biopsy specimens from the livers of 216 patients

188 erial tissue sections from paraffin-embedded needle biopsy specimens obtained at approximately 1 hr o

189 tion, PDGFRalpha expression in pre-operative needle biopsy specimens predicted poor overall survival

190 be useful in the interpretation of prostate needle biopsy specimens that are diagnostically challeng

191 chain reaction evidence of JCV infection in needle biopsy specimens with and without viral nephropat

192 cers assigned Gleason scores to the prostate needle biopsy specimens.

193 Foam cell arteriopathy was rarely seen in needle biopsy specimens.

194 ity of AMACR was evaluated using 94 prostate needle biopsy specimens.

195 y with which florid duct lesions are seen in needle-biopsy specimens of the liver was assessed in pat

196 computed tomography, FDG-PET, transthoracic needle biopsy, surgery, and watchful waiting.

197 s, pairing RNA samples from control prostate needle biopsy taken before intervention to RNA from the

198 When directly compared with the traditional needle biopsy technique, NMR was found to be more precis

199 through the application of the percutaneous needle biopsy technique.

200 for severe complications is lower with core-needle biopsy than with open surgical procedures (<1% vs

201 allow for the identification of G3 tumors on needle biopsies that are truly indolent versus those tha

202 t lesions (HRLs) diagnosed with image-guided needle biopsy that require surgical excision to be disti

203 esions entirely removed at percutaneous core needle biopsy that required wider excision underwent fre

204 Patients underwent MR imaging and fine-needle biopsy (the reference standard).

205 tomography (CT)-guided coaxial transthoracic needle biopsy, the authors fashioned an 18-gauge experim

206 plications, the probability of nondiagnostic needle biopsy, the sensitivity of computed tomography, a

207 grade prostatic intraepithelial neoplasia on needle biopsy--the most common precursor lesion to prost

208 hrough 4, among the 6706 men who underwent a needle biopsy, there were 220 tumors with a Gleason scor

209 tissue sites from fresh stereotactic breast needle biopsy tissue cores from 33 patients, including 5

210 We applied a new, needle biopsy tissue microarray (TMA) technique to study

211 includes the first xenografts generated from needle biopsy tissue obtained at diagnosis.

212 and 177 tissue samples (ie, resected or core-needle biopsied tissues).

213 , as well as measurements of tumor volume on needle biopsy to enhance the prediction in men undergoin

214 findings, fibrin bands or collagen, and core needle biopsy tract at microscopy.

215 Superimposing the recorded needle biopsy trajectories upon magnetic resonance/trans

216 he great increase in the utilization of core needle biopsies under mammographic and ultrasonographic

217 g the contribution of a patient's surgeon to needle biopsy use, and knowledge regarding downstream im

218 g nucleic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there should

219 hat CNA burden can be measured in diagnostic needle biopsies using low-input whole-genome sequencing,

220 from patients undergoing stereotactic breast needle biopsy, using a compact clinical Raman system.

221 Cost savings of stereotactic core needle biopsy vary in subgroups of patients defined acco

222 cer associated with ADH diagnosed using core needle biopsy vs excisional biopsy.

223 10 cases, an ultrasound-guided percutaneous needle biopsy was attempted on a protocol basis 10 days

224 Core-needle biopsy was performed at a tertiary care instituti

225 Needle biopsy was performed because of mammographic calc

226 aphy, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive diagnosi

227 For each lesion, image-guided core-needle biopsy was performed immediately after PET mammog

228 992 through February 1995, stereotactic core needle biopsy was performed in 356 women with 405 nonpal

229 Fourteen-gauge, automated needle biopsy was performed in 73 of these 113 lesions;

230 Needle biopsy was used in 68.4% (n = 61,353) of all pati

231 specificity, and accuracy of US-guided core-needle biopsy were calculated.

232 reast cancer was initially diagnosed by core-needle biopsy were more likely than women with cancer in

233 based on histological evaluation of prostate needle biopsies, which have high false negative rates.

234 Sextant prostate needle biopsies with ultrasound guidance.

235 Five patients also underwent core-needle biopsy with a coaxially introduced 20-gauge needl

236 One hundred eleven cases of core-needle biopsy with clip deployment were reviewed.

237 io (HR) of 3.0 (95% CI, 2-4.5) and, via core needle biopsy, with an adjusted HR of 2.2 (95% CI, 1.5-3

238 s author does not recommend a routine repeat needle biopsy within the first year following the diagno

239 sultation before versus after biopsy, use of needle biopsy (yes or no), and number of surgeries for c